Yukinori Okada, M.D., PhD, is a Professor at the University of Tokyo and the Osaka University Graduate School of Medicine as well as the Team Leader of the RIKEN Center for Integrative Medical Sciences. He received his M.D. (2005) and PhD (2011) from the University of Tokyo. His main research theme is elucidation of the mechanism whereby genetic variants in populations affect the clinical phenotypes of individuals, especially for autoimmune diseases and clinical biomarkers. Through active collaborative partnerships among researchers in the field of human genetics, Prof. Okada has conducted enormous genome-wide association studies (GWAS) of human complex traits and identified >15,000 novel genetic risk loci. He also has experience analyzing genetic variants in the major histocompatibility complex (MHC) region, including human leukocyte antigen (HLA) genes and the killer immunoglobulin receptor (KIR) region, which have substantial impacts on disease genetics and can act as clinical biomarkers. His interests are now moving towards genetic and bioinformatics analysis using multimodal human omics data generated by technologies in the post-GWAS era and the application of these data to novel drug discovery and drug repositioning, trans-omics analysis, single-cell sequencing, human evolution, and personalized medicine.